Literature DB >> 3360659

Residual radiation damage in murine lung assessed by pneumonitis.

N H Terry1, S L Tucker, E L Travis.   

Abstract

The amount of radiation damage remaining in mouse lung has been assessed by retreatment from 1 to 6 months after a range of first doses. Pneumonitis at 196 days after retreatment was used as the endpoint. Lungs were first irradiated with a range of single doses (6-10 Gy). Ten Gy was the highest dose that, on its own, produced no changes in breathing rate or deaths due to pneumonitis. One to 6 months later lungs were retreated with a full range of single doses. Isoeffect doses were calculated for lethality for all retreatment times after each priming dose. The amount of residual damage remaining in the lung has been calculated as both a proportion of first doses and as the effect equivalent of remembered dose. Following a 10 Gy first dose, there was evidence of remembered irradiation injury at all retreatment intervals. After a 6 Gy priming dose, the lungs could be retreated to tolerance. The amount of residual damage was proportional to the size of first dose and was highest at 1 month (27% after 6 Gy and 70% after 10 Gy) and lowest after 3 months (0% after 6 Gy and 46% after 10 Gy). This partial recovery of lung function between 1 and 3 months was followed by an increase in amount of damage "remembered"; that is, a reduction in the retreatment dose that could be delivered. The proportion of residual damage after 10 Gy was never less than 25%. The data suggest an early target cell depletion and regeneration in the lung (within 3 months), the extent of which is dependent on the size of initial injury.

Entities:  

Mesh:

Year:  1988        PMID: 3360659     DOI: 10.1016/0360-3016(88)90015-6

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

1.  Initial experience of hypofractionated radiation retreatment with true beam and flattening filter free beam in selected case reports of recurrent nasopharyngeal carcinoma.

Authors:  Filippo Alongi; Elena Clerici; Sara Pentimalli; Pietro Mancosu; Marta Scorsetti
Journal:  Rep Pract Oncol Radiother       Date:  2012-08-10

2.  Effect of total body irradiation on late lung effects: hidden dangers.

Authors:  Carl J Johnston; Casey Manning; Eric Hernady; Christina Reed; Sally W Thurston; Jacob N Finkelstein; Jacqueline P Williams
Journal:  Int J Radiat Biol       Date:  2011-05-17       Impact factor: 2.694

3.  Three-dimensional conformal reirradiation for locoregionally recurrent lung cancer previously treated with radiation therapy.

Authors:  Gil Ja Huh; Seong Soon Jang; Suk Young Park; Jae Hyuk Seo; Eun Youn Cho; Ji Chan Park; Young Jun Yang
Journal:  Thorac Cancer       Date:  2014-07-03       Impact factor: 3.500

4.  Gene expression profiles among murine strains segregate with distinct differences in the progression of radiation-induced lung disease.

Authors:  Isabel L Jackson; Fitsum Baye; Chirayu P Goswami; Barry P Katz; Andrew Zodda; Radmila Pavlovic; Ganga Gurung; Don Winans; Zeljko Vujaskovic
Journal:  Dis Model Mech       Date:  2017-01-26       Impact factor: 5.758

Review 5.  Stereotactic body radiation therapy in the re-irradiation situation--a review.

Authors:  Frederick Mantel; Michael Flentje; Matthias Guckenberger
Journal:  Radiat Oncol       Date:  2013-01-05       Impact factor: 3.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.